Ann Dermatol.  2018 Feb;30(1):97-99. 10.5021/ad.2018.30.1.97.

Tinea Incognito with Folliculitis-Like Presentation: A Case Series

• Kim MW
• Park HS
• Bae JM
• Yoon HS
• Cho S

• KMID: 2399765
• DOI: http://doi.org/10.5021/ad.2018.30.1.97

Abstract

No abstract available.

MeSH Terms

Tinea*

Figure

• 

  Fig. 1 Tinea incognito with folliculitis-like presentation. (A) Before treatment. (B) Complete resolution of skin lesions after 4 weeks of oral terbinafine. (C) Intracorneal pustules and superficial perivascular superficial perivascular lymphohistiocytic, eosinophilic and neutrophilic infiltration (H&E, ×100). (D) Fungal hyphae and spores (Gomori methenamine silver, ×200).

Reference

1. Kim WJ, Kim TW, Mun JH, Song M, Kim HS, Ko HC, et al. Tinea incognito in Korea and its risk factors: nine-year multicenter survey. J Korean Med Sci. 2013; 28:145–151. PMID: 23341725.

2. Ive FA, Marks R. Tinea incognito. Br Med J. 1968; 3:149–152. PMID: 5662546.

3. Jacobs JA, Kolbach DN, Vermeulen AH, Smeets MH, Neuman HA. Tinea incognito due to Trichophytom rubrum after local steroid therapy. Clin Infect Dis. 2001; 33:E142–E144. PMID: 11702294.

4. Park YW, Kim DY, Yoon SY, Park GY, Park HS, Yoon HS, et al. ‘Clues’ for the histological diagnosis of tinea: how reliable are they? Ann Dermatol. 2014; 26:286–288. PMID: 24882998.

5. Kye H, Kim DH, Seo SH, Ahn HH, Kye YC, Choi JE. Polycyclic annular lesion masquerading as lupus erythematosus and emerging as tinea faciei incognito. Ann Dermatol. 2015; 27:322–325. PMID: 26082592.